Finanzielle Vergleiche Longevity Health Holdings, Inc.
Aktien
A41867
US1429221294
XAGE
Biotechnologie
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
2.680 USD | -3.25% |
|
+9.84% | -67.99% |
08.07. | 20/20 GeneSystems, Inc. stoppt Übernahme von Longevity Health Holdings, Inc. im Rahmen einer Reverse-Merger-Transaktion | CI |
03.06. | Longevity Health erweitert Partnerschaft mit Humana | CI |
Hauptkonkurrenten
Umsatz (Y-1) | Nettogewinn (Y-1) | EBIT-Marge (Y-1) | ROE (Y-1) | ROA (Y-1) | Verschuldungsgrad (Y-1) | ||
---|---|---|---|---|---|---|---|
2.22 Mrd. | 36.99% | -0.96% | 2.26% | 2.02% | 234.49x | ||
5.38 Mrd. | 24.08% | 29.51% | 16.78% | 12.27% | -0.97x | ||
2.85 Mrd. | -24.18% | -47.77% | -3.3% | -2.88% | 9.36x | ||
364 Mio. | -251.24% | -241.47% | -1’601.19% | -54.47% | 0.16x | ||
2.56 Mrd. | 17.97% | 25.37% | 11.65% | 8.43% | -0.66x | ||
2.99 Mrd. | 36.44% | 32.53% | 22.97% | 19.34% | -2.97x | ||
291 Mio. | -24.22% | -26.28% | -8.94% | -4.69% | -2.82x | ||
2.17 Mrd. | 24.04% | 27.88% | 23.13% | 17.7% | -1.75x | ||
265 Mio. | -13.8% | -7.18% | -9.46% | -9.11% | 18.95x | ||
41.93 Mio. | -410.18% | -365.73% | - | - | - | ||
627 Mio. | -28.22% | -21.76% | -15.45% | -10.06% | 13.02x | ||
180 Mio. | -258.64% | -276.39% | -80.35% | - | 1.63x | ||
297 Mio. | 30.46% | 17.83% | 7.52% | 6.63% | -9.98x | ||
487 Mio. | 40.03% | 45.91% | 30.74% | 24.08% | - | ||
1.79 Mrd. | 6.64% | 9.69% | 4.89% | 1.76% | 4.17x | ||
235 Mio. | -85.53% | -78.53% | -54.06% | -26.62% | -1.54x | ||
Durchschnitt | 1.42 Mrd. | -54.96% | -54.84% | -110.19% | -1.11% | 18.65x | |
Gewichteter Durchschnitt nach Marktkapitalisierung | 2.09 Mrd. | -38.2% | -43.42% | -139.95% | -1.06% | 41.21x |
- Börse
- Aktien
- A41867 Aktie
- Sektor Longevity Health Holdings, Inc.
- Finanzielle Vergleiche
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen

MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben